Clinical trials: Dermatitis Hand

Hand-foot Syndrome

Study of Pyridoxine for Hand-Foot Syndrome

• Completed
• Age: 18 to 70 years
• Phase 3
• Results posted

Although pyridoxine has been used empirically for the prevention of capecitabine associated hand-foot syndrome (HFS), its efficacy needs to be demonstrated in prospective controlled trials.

Trial name

NCT00446147

Testing

Pyridoxine

Volunteers

389 people, healthy volunteers welcome

Sponsor

Asan Medical Center